Why the study?
Does calcium channel blocker therapy reduce cardiovascular morbidity and mortality compared to ACE inhibitors in diabetic hypertensive patients?
Does calcium channel blocker therapy reduce cardiovascular morbidity and mortality compared to ACE inhibitors in diabetic hypertensive patients?
The editorial challenges the historical consensus that ACE inhibitors are the sole preferred initial therapy for diabetic hypertensive patients, highlighting evidence for the benefits of calcium channel blockers.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Messerli et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: